Studies confirm regorafenib benefit in pre-treated metastatic colorectal cancer
3 July 2015 | By Victoria White
The Phase IIIb CONSIGN study has confirmed the benefit of regorafenib in patients with previously treated metastatic colorectal cancer (mCRC)...






























